David J. Straus, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, explores treatments for relapsed/refractory Hodgkins lymphoma, including nivolumab and pembrolizumab as well as ongoing studies evaluating CAR-T therapies in this patient population. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).